Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model

Thrombosis Research

Volumn 86, Issue 5, 1997, Pages 355-361

  Fu, Kaiding ^b,d   Izquierdo, Ricardo ^b   Vandevender, Darl ^b   Warpeha, Raymond L ^b   Wolf, Helmut ^c   Fareed, Jawed ^a  

^a Pediatric Plastic Surgery   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c Klinische Forschung   (Germany)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heparin; LMWH; Topical anticoagulants; Vascular trauma model

Indexed keywords

CERTOPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL INJURY; BLOOD VESSEL SHUNT; CONTROLLED STUDY; DRUG EFFECT; GRAFT PATENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOSIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANASTOMOSIS, SURGICAL; ANIMALS; ANTICOAGULANTS; ARTERIES; DISEASE MODELS, ANIMAL; EAR; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; MALE; RABBITS; THROMBOSIS;

EID: 0030747741     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00080-7     Document Type: Article

References (19)

1. KHOURI, K.R., BESIN, K., FU, K.D., ORNBERG, R.L. and WUN, T. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg 30, 398-404, 1993.
2. FU, K.D., IZQUIERDO, R., WALENGA, M.J. and FAREED, J. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model. Thromb Res 78, 421-428, 1995.
3. FU K.D., IZQUIERDO, R., HUBBARD, T. and FAREED, J. Modified crush-avulsion anastomosis model on the rat femoral vein. Microsurg 16, 536-541, 1995.
4. SINCLAIR, S. The importance of topical heparin in microvascular anastomoses: a study in the rat. Br J Plast Surg 33, 422-426, 1980.
5. FAREED, J. Comparative preclinical studies on various low molecular weight heparins. Haemostasis 18, 3-15, 1988.
6. FAREED, J. Chemical and biochemical heterogeneity in low molecular weight heparins: Implications for clinical use and standardization. Semin Thromb Hemost 15, 440-463, 1989.
7. KERSH, R.A., HANDREN, J., HERGRUETER, C. and MAY, J.W. Microvascular surgical experimental thrombosis model: Rationale and Design. Plast and Reconstr Surg 83, 866-872, 1989.
8. RAAKE, W. and ELLING, H. Rat jugular vein hemostasis - A new model for testing antithrombotic agents. Thromb Res 53, 73-77, 1989.
9. FAREED, J., WALENGA, J.M., KUMAR, A. and ROCK, A. A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractions. Semin Thromb Hemost 11, 155-175, 1985.
10. KRUPINSKI, K., BREDDIN, H.K., MARKWARDT, F. and HAARMANN, W. Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis. Haemostasis 19, 74-82, 1989.
11. LI, X., COOLEY, B.C. and GOULD, J.S. Influence of topical heparin on stasis-induced thrombosis of microvascular anastomoses. Microsurg 13, 72-75, 1992.
12. ZINBERG, E.M., CHOO, D.I. and ZOTTER, D.A. The effect of heparinized irrigating solutions on patency of experimental microvascular anastomoses. Microsurg 10, 103-107, 1989.
13. REICHEL, C.G. and PUCKETT, C.L. A comparison of irrigation solutions for microanastomoses. Am J Hand Surg 13, 33-36, 1988.
14. RUMBOLO, P.M., COOLEY, B.C., HANEL, D.P. and GOULD, J.S. Comparison of the influence of intraluminal irrigation solutions on free flap survival. Microsurg 13, 45-47, 1992.
15. WIESLANDER, J.B. and DOUGAN, P. Washout of vessel with heparin does not improve patency following severe microarterial trauma: An experimental study. Ann Plast Surg 24, 216-222, 1990.
16. SAVIE, F.H., COOLEY, B.C. and GOULD, J.S. Evaluation of the effect of pharmacologic agents on crush-avulsion arterial injuries: A scanning electron microscopy study. Microsurg 12, 292-300, 1991.
17. FAREED, J., HOPPENSTEADT, D., WALENGA, J.M. and BECK, R.L. Current trends in the development of anticoagulant and antithrombotic drugs. Medical Clinics of North America 78, 713-729, 1994.
18. WOLF, H. Low-molecular-weight heparin. Medical Clinics of North America 78, 733-741, 1994.
19. FAREED, J., HOPPENSTEADT, D. and WALENGA, J.M. Current respectives on low molecular weight heparins. Semin Thromb Hemost 19, 1-10, 1993.